Stifel
http://www.stifel.com
Stifel Financial Corp. is a full-service regional brokerage and investment banking firm, established in 1890 and based in St. Louis, Missouri.
The Company provides securities brokerage, investment banking, trading, investment advisory, and related financial services through its wholly owned subsidiaries, primarily Stifel, Nicolaus & Company, Incorporated, to individual investors, professional money managers, businesses, and municipalities.
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) PT Raised to $18 at Stifel: Haduvio Development up in 2026
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) PT Raised to $12 at Stifel
-
-
-
-
-
-
-
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) Announces Proposed Public Offering of Common Stock, Warrants
-
-
-
-
-
-
-
Trevi Therapeutics Announces $11.8 Million Private Placement Priced At-the-Market
-
-
-
-
-
-
-
Trevi Therapeutics (TRVL) Prices 5.5M Share IPO at $10/Sh
-
43,031 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

